PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
56.03
-1.56 (-2.71%)
Mar 13, 2025, 4:00 PM EST - Market closed
PROCEPT BioRobotics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for PROCEPT BioRobotics stock have an average target of 94.29, with a low estimate of 75 and a high estimate of 112. The average target predicts an increase of 68.28% from the current stock price of 56.03.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PROCEPT BioRobotics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $105 → $95 | Buy | Maintains | $105 → $95 | +69.55% | Feb 26, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $105 → $90 | Strong Buy | Reiterates | $105 → $90 | +60.63% | Feb 26, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $112 | Buy | Initiates | $112 | +99.89% | Dec 3, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $105 | Buy | Initiates | $105 | +87.40% | Dec 2, 2024 |
| Jefferies | Jefferies | Hold Initiates $95 | Hold | Initiates | $95 | +69.55% | Nov 14, 2024 |
Financial Forecast
Revenue This Year
328.40M
from 224.50M
Increased by 46.28%
Revenue Next Year
435.69M
from 328.40M
Increased by 32.67%
EPS This Year
-1.35
from -1.75
EPS Next Year
-0.79
from -1.35
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 352.8M | 474.1M | 632.8M | ||
| Avg | 328.4M | 435.7M | 553.8M | ||
| Low | 313.2M | 401.7M | 481.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 57.1% | 44.4% | 45.2% | ||
| Avg | 46.3% | 32.7% | 27.1% | ||
| Low | 39.5% | 22.3% | 10.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.11 | -0.60 | 0.01 | ||
| Avg | -1.35 | -0.79 | -0.15 | ||
| Low | -1.49 | -1.09 | -0.29 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.